Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis
- PMID: 34847624
- DOI: 10.1002/ptr.7337
Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis
Abstract
Alnustone, a diarylheptane compound, exhibits potent growth inhibition against hepatocellular carcinoma (HCC) BEL-7402 cells. However, the underlying mechanisms associated with its anticancer activity remain unknown. In the present study, we evaluated the anticancer effect of alnustone against several human cancers focused on HCC and the possible associated mechanisms. The results showed that alnustone significantly inhibited the growth of several cancer cells by CCK-8 assay. Alnustone markedly induced apoptosis and decreased mitochondrial membrane potential in BEL-7402 and HepG2 cells. Alnustone inhibited the expression of proteins related to apoptosis and PI3K/Akt/mTOR/p70S6K pathways and generated ROS production in BEL-7402 and HepG2 cells. Moreover, N-acetyl-L-cysteine (NAC, a ROS inhibitor) could significantly reverse the effects of alnustone on the growth inhibition of BEL-7402 and HepG2 cells and the expression of proteins related to apoptosis and PI3K/Akt/mTOR signaling pathway in HepG2 cells. Furthermore, alnustone significantly inhibited tumor growth of HepG2 xenografts, obviously induced apoptosis in the tumor tissues and improved the pathological condition of liver tissues of mice in vivo. The study provides evidence that alnustone is effective against HCC via ROS-mediated PI3K/Akt/mTOR/p70S6K pathway and the compound has the potential to be developed as a novel anticancer agent for the treatment of HCC clinically.
Keywords: PI3K/Akt/mTOR/p70S6K signaling pathway; alnustone; human hepatocellular carcinoma; reactive oxygen species.
© 2021 John Wiley & Sons, Ltd.
Similar articles
-
Comment on: Alnustone inhibits the growth of hepatocellular carcinoma via reactive oxygen species-mediated PI3K/Akt/mTOR/p70S6K axis.Phytother Res. 2023 Jun;37(6):2215-2216. doi: 10.1002/ptr.7708. Epub 2022 Dec 22. Phytother Res. 2023. PMID: 36560899 No abstract available.
-
Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.Carcinogenesis. 2013 Jun;34(6):1331-42. doi: 10.1093/carcin/bgt060. Epub 2013 Feb 7. Carcinogenesis. 2013. PMID: 23393227
-
SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.Cancer Sci. 2012 Nov;103(11):1929-37. doi: 10.1111/j.1349-7006.2012.02409.x. Epub 2012 Sep 25. Cancer Sci. 2012. PMID: 22909393 Free PMC article.
-
[EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].Pathologe. 2014 Nov;35 Suppl 2:177-84. doi: 10.1007/s00292-014-2007-y. Pathologe. 2014. PMID: 25394965 Review. German.
-
Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.J Cell Physiol. 2020 May;235(5):4146-4152. doi: 10.1002/jcp.29333. Epub 2019 Oct 29. J Cell Physiol. 2020. PMID: 31663122 Review.
Cited by
-
Synthesis of alnustone-like diarylpentanoids via a 4 + 1 strategy and assessment of their potential anticancer activity.Turk J Chem. 2023 Oct 11;47(5):1249-1259. doi: 10.55730/1300-0527.3609. eCollection 2023. Turk J Chem. 2023. PMID: 38173735 Free PMC article.
-
Molecular basis of acute coronary syndrome.J Res Med Sci. 2022 May 30;27:40. doi: 10.4103/jrms.jrms_695_21. eCollection 2022. J Res Med Sci. 2022. PMID: 35968216 Free PMC article. Review.
-
Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma.Front Oncol. 2022 Jun 16;12:920652. doi: 10.3389/fonc.2022.920652. eCollection 2022. Front Oncol. 2022. PMID: 35785216 Free PMC article. Review.
-
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.Clin Transl Oncol. 2022 Mar;24(3):471-482. doi: 10.1007/s12094-021-02716-4. Epub 2021 Oct 13. Clin Transl Oncol. 2022. PMID: 34643878 Review.
References
REFERENCES
-
- An, W., Lai, H., Zhang, Y., Liu, M., Lin, X., & Cao, S. (2019). Apoptotic pathway as the therapeutic target for anticancer traditional Chinese medicines. Frontiers in Pharmacology, 10, 758. https://doi.org/10.3389/fphar.2019.00758
-
- Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018). Kinase-targeted cancer therapies: Progress, challenges and future directions. Molecular Cancer, 17(1), 48. https://doi.org/10.1186/s12943-018-0804-2
-
- Bray, F., Ferlay, J., Soerjomataram, I., Torre, L. A., Siegel, R. L., & Jemal, A. (2018). Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 392-424. https://doi.org/10.3322/caac.21492
-
- Cao, S., McGuire, J. J., & Rustum, Y. M. (1999). Antitumor activity of ZD1694 against human head and neck cancer in nude mice models: Role of dosing schedule and plasma thymidine. Clinical Cancer Research, 5(7), 1925-1934.
-
- Cheng, H., Jiang, X., Zhang, Q., Ma, J., Cheng, R., Yong, H., … Gao, G. (2020). Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway. Experimental and Therapeutic Medicine, 19(6), 3798-3804.
MeSH terms
Substances
Grants and funding
- 2015-RCYJ0002/Distinguished Professor Research Startup Funding from Southwest Medical University
- ZR2020QH360/Natural Science Foundation in Shandong Province of China
- ZR2020MH420/Natural Science Foundation in Shandong Province of China
- ZR2020MH421/Natural Science Foundation in Shandong Province of China
- 2017YFE0195000/International Collaborative Project of the MOST of China
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
